242 related articles for article (PubMed ID: 33260723)
21. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
[TBL] [Abstract][Full Text] [Related]
22. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
Heise CW; Brooks DE
J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
[TBL] [Abstract][Full Text] [Related]
23. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
[TBL] [Abstract][Full Text] [Related]
24. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
Wang YH; Samoylenko V; Tekwani BL; Khan IA; Miller LS; Chaurasiya ND; Rahman MM; Tripathi LM; Khan SI; Joshi VC; Wigger FT; Muhammad I
J Ethnopharmacol; 2010 Apr; 128(3):662-71. PubMed ID: 20219660
[TBL] [Abstract][Full Text] [Related]
25. Ayahuasca Alters Structural Parameters of the Rat Aorta.
Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC
J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595
[TBL] [Abstract][Full Text] [Related]
26. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
27. Ayahuasca: What Healthcare Providers Need to Know.
Goldin D; Salani D
J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
[TBL] [Abstract][Full Text] [Related]
28. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
[TBL] [Abstract][Full Text] [Related]
29. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
[TBL] [Abstract][Full Text] [Related]
30. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
[TBL] [Abstract][Full Text] [Related]
31. Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil.
Souza RCZ; Zandonadi FS; Freitas DP; Tófoli LFF; Sussulini A
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():197-203. PubMed ID: 31220748
[TBL] [Abstract][Full Text] [Related]
32. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
[TBL] [Abstract][Full Text] [Related]
33. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca.
Yritia M; Riba J; Ortuño J; Ramirez A; Castillo A; Alfaro Y; de la Torre R; Barbanoj MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):271-81. PubMed ID: 12361741
[TBL] [Abstract][Full Text] [Related]
34. Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review.
Simão AY; Gonçalves J; Duarte AP; Barroso M; Cristóvão AC; Gallardo E
Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31635364
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca.
Gonçalves J; Luís Â; Gallardo E; Duarte AP
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144509
[TBL] [Abstract][Full Text] [Related]
36. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
[TBL] [Abstract][Full Text] [Related]
37. New Insights into the Chemical Composition of Ayahuasca.
Rodríguez L; López A; Moyna G; Seoane GA; Davyt D; Vázquez Á; Hernández G; Carrera I
ACS Omega; 2022 Apr; 7(14):12307-12317. PubMed ID: 35449956
[TBL] [Abstract][Full Text] [Related]
38. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
Favaro VM; Yonamine M; Soares JC; Oliveira MG
PLoS One; 2015; 10(12):e0145840. PubMed ID: 26716991
[TBL] [Abstract][Full Text] [Related]
39. Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use.
Perkins D; Ruffell SGD; Day K; Pinzon Rubiano D; Sarris J
Front Neurosci; 2022; 16():879221. PubMed ID: 36798604
[TBL] [Abstract][Full Text] [Related]
40. Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry.
Gaujac A; Dempster N; Navickiene S; Brandt SD; de Andrade JB
Talanta; 2013 Mar; 106():394-8. PubMed ID: 23598143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
